Skip to main content
padlock icon - secure page this page is secure

Carfilzomib‐containing combinations as frontline therapy for multiple myeloma: A meta‐analysis of 13 trials

Buy Article:

$59.00 + tax (Refund Policy)

To investigate the activity and safety of carfilzomib‐containing combinations as frontline therapy for multiple myeloma.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: carfilzomib; frontline; meta‐analysis; multiple myeloma

Document Type: Research Article

Publication date: June 1, 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more